Sign in
SuspendedNo phase

Upper GI Serial Tumour Biopsies

Key facts

Who runs it
The Christie NHS Foundation Trust
Where
United Kingdom1 site in 1 countryChoose a country to see its locations
Trial code
Status
Suspended
People taking part
300 people, planned
Started
25 Jan 2022
Expected to end
Oct 2028
Type of study
Observational
Treatments tested
  • Minor endoscopic biopsy
Record updated
8 February 2024
Why it stopped
To explore alternative funding streams

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Age of 18 years or more
  • Patients must have given written informed consent
  • Evidence of locally advanced or metastatic oesophageal and gastric carcinoma, i.e. stage III or IV disease
  • Accessible tumour that can be safely biopsied using radiological or surgical techniques (if consenting to part A)
  • Full blood count and coagulation tests within acceptable parameters (if consenting to part A)

Who cannot take part

  • History of significant bleeding disorder (patients on anticoagulation are eligible if the anticoagulation can be safely managed to allow fresh tumour biopsies and blood sampling)
  • History of HIV, Hepatitis B/C or other transmissible human disease
  • Any conditions where research biopsies or blood sampling may increase risk of complications for the patient and/or investigator, including high risk groups such as intravenous drug users
  • Inability to provide informed consent

Where is this trial?

It has locations in one country. Choose a country to see its locations.

What happens in this trial

What the trial wants to find out

This is a prospective translational research study in which tumour samples, blood samples and other biospecimens will be requested from patients with locally advanced or metastatic malignant oesophageal and gastric carcinoma. There are two parts to the study:

Read full original descriptionShow less

* Part A - evaluation of serial tumour biopsies * Part B - evaluation of circulating biomarkers and other biospecimens

The group in the trial

  • All participants

    All eligible, consented participants, will be asked to give blood, tissue, and other biospecimens for research purposes

    Treatment: Minor endoscopic biopsy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Molecular Characterisation of Serial Tumour Samples and Their Correlation With Circulating Biomarkers and Other Biospecimens Taken During the Clinical Course of Patients Receiving Treatment for Upper Gastrointestinal Carcinomas.
Record updated
8 February 2024